Literature DB >> 26791121

A man with dark urine and shortness of breath: a case-based review of paravalvular leaks.

James P Curtain1, James William O'Brien1.   

Abstract

A 62-year-old man presented to his general practitioner with a 10-day history of dark red urine. Subsequent blood tests revealed an acute kidney injury and anaemia. His only medical history was a prosthetic mitral valve replacement 30 years previously for rheumatic valve disease. Following referral to a urology service, initial investigations, including CT KUB (kidneys, ureters, bladder), excluded a urological cause for his presentation. A haemolysis screen was positive. A transthoracic echocardiogram reported severe aortic stenosis and aortic incompetence. A transoesophageal echocardiogram revealed a paravalvular leak at the prosthetic mitral valve. The patient was referred to a regional cardiothoracic centre, and underwent a repeat mitral valve replacement and an aortic valve replacement. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 26791121      PMCID: PMC4735420          DOI: 10.1136/bcr-2015-213399

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

1.  Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial.

Authors:  K Hammermeister; G K Sethi; W G Henderson; F L Grover; C Oprian; S H Rahimtoola
Journal:  J Am Coll Cardiol       Date:  2000-10       Impact factor: 24.094

2.  Does the morphology of mitral paravalvular leaks influence symptoms and hemolysis?

Authors:  M Genoni; D Franzen; R Tavakoli; B Seiffert; K Graves; R Jenni; M Turina
Journal:  J Heart Valve Dis       Date:  2001-07

Review 3.  Erythropoietin can obviate the need for repeated heart valve replacement in high-risk patients with severe mechanical hemolytic anemia: case reports and literature review.

Authors:  Y Shapira; O Bairey; M Vatury; H Magen-Nativ; M Prokocimer; A Sagie
Journal:  J Heart Valve Dis       Date:  2001-07

4.  Percutaneous repair of paravalvular prosthetic regurgitation: acute and 30-day outcomes in 115 patients.

Authors:  Paul Sorajja; Allison K Cabalka; Donald J Hagler; Charanjit S Rihal
Journal:  Circ Cardiovasc Interv       Date:  2011-07-26       Impact factor: 6.546

5.  Hemolysis and acute kidney failure.

Authors:  Qi Qian; Karl A Nath; Yiming Wu; Tarek M Daoud; Sanjeev Sethi
Journal:  Am J Kidney Dis       Date:  2010-06-03       Impact factor: 8.860

6.  Redo aortic valve surgery: Influence of prosthetic valve endocarditis on outcomes.

Authors:  Sergey Leontyev; Michael A Borger; Paul Modi; Sven Lehmann; Jörg Seeburger; Thomas Walther; Friedrich W Mohr
Journal:  J Thorac Cardiovasc Surg       Date:  2010-10-15       Impact factor: 5.209

7.  Prevalence and clinical significance of incidental paraprosthetic valvar regurgitation: a prospective study using transoesophageal echocardiography.

Authors:  A Ionescu; A G Fraser; E G Butchart
Journal:  Heart       Date:  2003-11       Impact factor: 5.994

8.  Prevalence and severity of paravalvular regurgitation in the Artificial Valve Endocarditis Reduction Trial (AVERT) echocardiography study.

Authors:  Victor G Dávila-Román; Alan D Waggoner; Elizabeth D Kennard; Richard Holubkov; W R Eric Jamieson; Lars Englberger; Thierry P Carrel; Hartzell V Schaff
Journal:  J Am Coll Cardiol       Date:  2004-10-06       Impact factor: 24.094

Review 9.  Risk of repeat mitral valve replacement for failed mitral valve prostheses.

Authors:  D Dean Potter; Thoralf M Sundt; Kenton J Zehr; Joseph A Dearani; Richard C Daly; Charles J Mullany; Christopher G A McGregor; Francisco J Puga; Hartzell V Schaff; Thomas A Orszulak
Journal:  Ann Thorac Surg       Date:  2004-07       Impact factor: 4.330

Review 10.  Review of surgical prosthetic paravalvular leaks: diagnosis and catheter-based closure.

Authors:  Chad Kliger; Rocio Eiros; Guillermo Isasti; Bryce Einhorn; Vladimir Jelnin; Howard Cohen; Itzhak Kronzon; Gila Perk; Gregory P Fontana; Carlos E Ruiz
Journal:  Eur Heart J       Date:  2012-11-01       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.